These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14431735)

  • 1. [Study of the plasmatic protein picture in peripheral obliterative arteriopathies in relation to treatment with acetylcholine for arterioclysis].
    PEREGO MA; ALLORI L; PATRIGNANI S; SONNINO S
    Atti Soc Ital Cardiol; 1959; 21(2)():Comunicazioni 110-2. PubMed ID: 14431735
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intra-arterial therapy in peripheral arteriopathies].
    BUZZI A
    Med Panam; 1959 Aug; 13():139-54. PubMed ID: 13806598
    [No Abstract]   [Full Text] [Related]  

  • 3. [Syncardial massage in the treatment of peripheral chronic obliterating arteriopathies].
    TESSAROLO N; MARIOT A
    Acta Chir Ital; 1959; 15():717-35. PubMed ID: 13837579
    [No Abstract]   [Full Text] [Related]  

  • 4. [A possibility of etiologic conservative therapy of obliterative peripheral arterial diseases. (Critical review of the literature)].
    MADAR J; UHRIK J
    Zb Lek Fak Kosice; 1961; 4(2-3)():185-200. PubMed ID: 14468091
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of peripheral arterial obliterative diseases and their complications by arterial infusions of histamine.
    MUFSON I
    Am J Med; 1952 Jun; 12(6):680-7. PubMed ID: 14933445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of peripheral arteriopathies with the combination of a vasodilator and a vasotonic].
    SAVIO O
    Minerva Med; 1960 May; 51():1962-6. PubMed ID: 14442064
    [No Abstract]   [Full Text] [Related]  

  • 7. A new approach to the management of obliterative peripheral arterial disease.
    CASTEN GG; GILMORE HR; HOUGHTON FE; SAMUELS SS
    Angiology; 1960 Oct; 11():408-14. PubMed ID: 13691417
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the use in medical therapy of peripheral arteriopathies of an enzymatic complex in association with a peripheral vasodilator].
    STARACE G; NOFERI A
    Minerva Cardioangiol; 1959 Oct; 7():545-50. PubMed ID: 13833816
    [No Abstract]   [Full Text] [Related]  

  • 9. [DRUG THERAPY OF OBLITERATIVE PROCESSES OF PERIPHERAL ARTERIOPATHIES].
    STRANO A
    Med Welt; 1965 Mar; 12():603-9. PubMed ID: 14293113
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1].
    FERRANTE G; GRASS IM; NEGRO G
    Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of chronic obliterative arteriopathies treated with lytic-cocktail.
    BAZAN M
    Panminerva Med; 1959 Oct; 1():240-2. PubMed ID: 13797848
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness and mode of action of nialamide in peripheral, arterial circulatory disorders].
    HUPKA K; THALER H
    Chemotherapia (Basel); 1962; 4():102-11. PubMed ID: 14450094
    [No Abstract]   [Full Text] [Related]  

  • 13. [A treatment plan for peripheral arterial vascular disorders].
    MOSER F
    Dtsch Med Wochenschr; 1959 Sep; 84():1613-7. PubMed ID: 14424525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Another method of treatment of peripheral arterial diseases].
    MOLLA W
    Osp Maggiore; 1955 Oct; 43(10):498-501. PubMed ID: 13289118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparin treatment of peripheral arterial diseases].
    DI FRANCO S; FURITANO G
    Atti Soc Ital Cardiol; 1956; 1():340-1. PubMed ID: 13328702
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral arterial disorders.
    SAMUELS SS
    Med Times; 1960 Mar; 88():332-5. PubMed ID: 14441295
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the therapy of arterial peripheral circulatory diseases].
    BUSCHMANN W
    Z Gesamte Inn Med; 1960 Feb; 15():187-97. PubMed ID: 13806386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prolonged treatment of peripheral arterial diseases with Tromexan].
    LANFRANCHI W; DEGNI M
    Arq Bras Med; 1960; 50():499-502. PubMed ID: 14462031
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of sympathicolytic therapy in peripheral arterial diseases].
    VITTORI N; GUAGLIANO G; VITTORI C
    Minerva Cardioangiol; 1962 May; 10():281-5. PubMed ID: 13926310
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes of the arteriolo-capillary circulation in subjects of chronic peripheral obliterating arteriopathy after treatment with 1, 1-(beta-hydroxypropyl)-theobromine].
    GUAGLIANO G; STOPPANI L; VITTORI F
    Minerva Med; 1959 Nov; 50():3815-9. PubMed ID: 13829927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.